Proteomic Analysis of Human Hepatocellular Carcinoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 75 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Arm A: Hepatocellular carcinoma with vessel invasion:
hepatocellular carcionoma, pathologic diagnosed.
image documented vessel invasion, including portal vein thrombosis
eligible for surgical intervension.
Arm B: hepatocellular carcinoma without vessel invasion:
hepatocellular carcinoma, pathologic diagnosed or clinical diagnosed according to EASL criteria.